Submit your Zyprexa claim details for a free, no obligation case review
Get Started:
Zyprexa safety issues are important to understand if you are taking or considering Zyprexa use. Zyprexa is one of a number of second generation antipsychotic (SGA) drugs prescribed to treat schizophrenia and bipolar disorder. Zyprexa (whose generic name is olanzapine) is the progeny of Eli Lilly, a pharmaceutical giant based in the United States. Since it received FDA approval in 1996, Zyprexa has been used by over fourteen million people worldwide. Zyprexa safety has become a serious issue because studies have found that taking Zyprexa greatly increases a patient''s chances of developing Diabetes and other potentially fatal glucose abnormalities.
In 2002 British and Japanese authorities, concerned about Zyprexa safety, ordered Eli Lilly to change their Zyprexa safety information package insert to describe the increased risk of developing diabetes associated with Zyprexa use. Then in September of 2003, the United States'' Federal Drug Administration ordered Eli Lilly to do the same for all Zyprexa marketed in the United States. American concerns about Zyprexa safety arrived on the coattails of foreign scrutiny and the results of two major Zyprexa safety studies.
The British Medical Journal and Duke University''s Pharmacotherapy journal both published studies regarding Zyprexa safety in 2002. Both of these studies found a causal relationship between the development or worsening of Diabetes Mellitus and hyperglycemia and the use of Zyprexa. They found that the onset of these serious life-threatening conditions can be rapid and acute and can occur irrespective of a patient''s Zyprexa dose. The Zyprexa safety risk of developing these conditions may not disappear even when a patient stops taking Zyprexa.
Zyprexa safety information suggests that patients who have diabetes be strictly monitored for any changes in their condition. Zyprexa patients who are at risk for developing diabetes should undergo fasting glucose testing prior to taking Zyprexa and routinely during treatment. The development of hyperglycemia and diabetes symptoms should be a serious Zyprexa safety concern. Any change in blood pressure or heart rate, labored breathing, increased hunger, thirst, or urination, unexplained weight loss or fatigue, slowed healing processes, stomach problems, headache, or motor problems may indicate hyperglycemia or diabetes problems.
Other Zyprexa safety concerns may involve other Zyprexa side effects including fatigue, dizziness, weakness, motor problems, weight gain, indigestion, dry mouth, weight gain, and seizures. If you are taking or considering Zyprexa, it is important to speak to your health care professional about Zyprexa safety in light of your specific medical history and present condition.
If you have been the victim of an injury or serious health problem because of Zyprexa use, you may be eligible to file a claim against Eli Lilly to seek compensation for your injuries. A professional personal injury attorney can help to maximize and protect your interests in a Zyprexa injury case.
On March 6, 2008, the State of Alaska provided its opening arguments in a lawsuit against the maker of the schizophrenia drug Zyprexa.
The lawsuit contends that the pharmaceutical giant Eli Lilly played down the diabetes and weight gain The maker of the popular antipsychotic drug Zyprexa is in talks to settle state and federal claims over the company’s marketing practices for more than $1 billion, potentially the... Strong new warnings were added to the label of the top-selling antipsychotic Zyprexa last week, alerting patients and physicians to the increased risk of high blood sugar and » Read More "Makers of Zyprexa may Settle Suit"
"High Blood Sugar and Weight Gain Risks"
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice